Clinical Trial Update: Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease? [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial is enrolling by invitation to evaluate whether Bacillus Calmette-Guérin (BCG) vaccination can reduce biomarkers associated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Late-onset

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Tamir Ben-Hur | Conditions: Alzheimer Disease, Late Onset | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION